Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Ipsen Biopharmaceuticals, Inc.
Start Date
December 13, 2016
End Date
May 31, 2022
Administered By
Duke Cancer Institute
Awarded By
Ipsen Biopharmaceuticals, Inc.
Start Date
December 13, 2016
End Date
May 31, 2022